CORCEPT THERAPEUTICS INC — Director's Dealing 2012

Jun 15, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CORCEPT THERAPEUTICS INC (CORT)
CIK: 0001088856
Period of Report: 2012-06-13

Reporting Person: ENRIGHT PATRICK G (Director, 10% Owner)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-06-13	Stock Options (right to buy)	$4.05	A	30000	Acquired	2022-06-13	COMMON STOCK (30000)	Direct

Footnotes

F1: The vesting period of the options commenced on the grant date, with 8.3334% of the options to vest on each monthly anniversary of the grant date and the final vesting of all remaining options to occur on or before the date of the Issuer's 2013 Annual Meeting of Stockholders. The reporting person shares pecuniary interest in these securities with other individuals pursuant to a contractual relationship. The reporting person disclaims beneficial ownership of these securities except as to the extent of the reporting person's pecuniary interest in these securities.

F2: Does not include (i) options held by the reporting person to purchase 70,000 shares of the Issuer's common stock at an exercise price equal to $2.23 per share that expire on June 10, 2018, (ii) options held by the reporting person to purchase 30,000 shares of the Issuer's common stock at an exercise price equal to $0.96 per share that expire on June 11, 2019, (iii) options held by the reporting person to purchase 30,000 shares of the Issuer's common stock at an exercise price equal to $3.47 per share that expire on June 23, 2020, and (iv) options held by the reporting person to purchase 30,000 shares of the Issuer's common stock at an exercise price equal to $4.42 per share that expire on May 19, 2021.